UniProt ID | Protein Name | Gene Symbol | No. of Glycosylation Sites | No. of GlyTouCan IDs | Disease Ontology |
---|---|---|---|---|---|
A0A7K9S1I4 | Hyaluronidase (Fragment) |
|
1 | 0 |
|
A0A7K9SEL7 | Fibroblast growth factor receptor 2 (Fragment) |
|
8 | 0 |
|
A0A7K9RLG5 | KCNKG protein (Fragment) |
|
1 | 0 |
|
A0A7K9RCX8 | Pannexin (Fragment) |
|
1 | 0 |
|
A0A7K9RNF1 | BACE2 secretase (Fragment) |
|
1 | 0 |
|
A0A7K9S1M5 | Hyaluronidase (Fragment) |
|
1 | 0 |
|
A0A7K9RQ07 | Hyaluronidase (Fragment) |
|
1 | 0 |
|
A0A7K9RIM0 | Fibroblast growth factor receptor 1 (Fragment) |
|
8 | 0 |
|
A0A7K9S6B8 | Protein adenylyltransferase FICD (Fragment) |
|
1 | 0 |
|
A0A7K9RX97 | N-acetylgalactosamine-6-sulfatase (Fragment) |
|
1 | 0 |
|
A0A7K9RU56 | Rhodopsin (Fragment) |
|
2 | 0 |
|
A0A7K9S2W8 | Pannexin (Fragment) |
|
1 | 0 |
|
A0A7K9S580 | ATP receptor (Fragment) |
|
1 | 0 |
|
A0A7K9S0M4 | NOGG protein (Fragment) |
|
1 | 0 |
|
A0A7K9RDB8 | Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase (Fragment) |
|
1 | 0 |
|
A0A7K9RS80 | Hyaluronidase (Fragment) |
|
1 | 0 |
|
A0A7K9RV03 | Angiotensin-converting enzyme (Fragment) |
|
2 | 0 |
|
A0A7K9RZ88 | Voltage-dependent L-type calcium channel subunit alpha (Fragment) |
|
1 | 0 |
|
A0A7K9RQJ7 | Rhodopsin (Fragment) |
|
2 | 0 |
|
A0A7K9S7U0 | Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase (Fragment) |
|
1 | 0 |
|
A0A7K9RX24 | Voltage-dependent L-type calcium channel subunit alpha (Fragment) |
|
1 | 0 |
|
A0A7K9RJT0 | Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase (Fragment) |
|
1 | 0 |
|
A0A7K9RUV5 | AMD monooxygenase (Fragment) |
|
1 | 0 |
|
A0A7K9RMN3 | Voltage-dependent L-type calcium channel subunit alpha (Fragment) |
|
1 | 0 |
|
A0A7K9S9X2 | P2X purinoceptor (Fragment) |
|
1 | 0 |
|
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.0.0
Last updated: August 19, 2024